Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists.

World journal of gastroenterology - 21 Sept 2016

Fusco Nicola, Bosari Silvano

Abstract excerpt

Management of cancers of the digestive system has progressed rapidly into the molecular era. Despite the significant recent achievements in the diagnosis and treatment of these patients, the number of deaths for these tumors has currently plateaued. Many investigations have assessed the role of HER2 in tumors of the digestive system in both prognostic and therapeutic settings, with heterogeneous results. Novel...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biliary Tract Neoplasms
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Pancreatic Ductal

Share to Esophageal Neoplasms

Share to Gastrointestinal Neoplasms

Share to Genes, erbB-2

Share to Liver Neoplasms

Share to Receptor, ErbB-2

Source

Open in PubMed Open full text

Identifiers

PMID: 27672288
DOI: 10.3748/wjg.v22.i35.7926
PMCID: PMC5028807

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists.PMID 27672288Read ↗

Targeting ERBB2/HER2 genetic alterations: an expanding therapeutic opportunity in gastrointestinal cancers.Semantic proximity Read ↗

Genetic Profiling of Cancers of the Digestive System: Biological Insights and Clinical Implications.Semantic proximity Read ↗

HER2 in solid tumors: more than 10 years under the microscope; where are we now?Semantic proximity Read ↗

HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.Semantic proximity Read ↗

Current and future therapies for targeting HER2 mutations in gastrointestinal cancer.Semantic proximity Read ↗

HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic SchemesSemantic proximity Read ↗

A Comprehensive Review of HER2 in Cancer Biology and TherapeuticsSemantic proximity Read ↗

A Comprehensive Review of HER2 in Cancer Biology and TherapeuticsSemantic proximity Read ↗

The current state of molecular profiling in gastrointestinal malignancies.Semantic proximity Read ↗

Clinical impact of tumour biology in the management of gastroesophageal cancer.Semantic proximity Read ↗

Molecular targets in GI malignancies - A pathologist's perspective.Semantic proximity Read ↗

Genomics and Targeted Therapies in Gastroesophageal AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.